{
    "organizations": [],
    "uuid": "5d0fb4e03dce5316e48d076548ae85d47033a125",
    "author": "",
    "url": "https://www.reuters.com/article/brief-valeant-and-one-of-its-subsidiarie/brief-valeant-and-one-of-its-subsidiaries-commence-cash-tender-offers-for-up-to-1250000000-outstanding-principal-amount-idUSASC09RQO",
    "ord_in_thread": 0,
    "title": "BRIEF-Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,250,000,000 Outstanding Principal Amount",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 12, 2018 / 11:45 AM / Updated 22 minutes ago BRIEF-Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,250,000,000 Outstanding Principal Amount Reuters Staff 1 Min Read March 12 (Reuters) - Valeant Pharmaceuticals International Inc: * VALEANT AND ONE OF ITS SUBSIDIARIES COMMENCE CASH TENDER OFFERS FOR UP TO $1,250,000,000 OUTSTANDING PRINCIPAL AMOUNT * VALEANT - ‍TENDER OFFERS FOR NOTES WILL EXPIRE ON APRIL 9, 2018​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-12T13:43:00.000+02:00",
    "crawled": "2018-03-12T13:57:02.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "one",
        "subsidiary",
        "commence",
        "cash",
        "tender",
        "offer",
        "outstanding",
        "principal",
        "amount",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "valeant",
        "pharmaceutical",
        "international",
        "inc",
        "valeant",
        "one",
        "subsidiary",
        "commence",
        "cash",
        "tender",
        "offer",
        "outstanding",
        "principal",
        "amount",
        "valeant",
        "offer",
        "note",
        "expire",
        "april",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}